TW200740444A - Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitor - Google Patents

Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitor

Info

Publication number
TW200740444A
TW200740444A TW095131384A TW95131384A TW200740444A TW 200740444 A TW200740444 A TW 200740444A TW 095131384 A TW095131384 A TW 095131384A TW 95131384 A TW95131384 A TW 95131384A TW 200740444 A TW200740444 A TW 200740444A
Authority
TW
Taiwan
Prior art keywords
muscle pain
fermented milk
potency
pain inhibitor
manufacture
Prior art date
Application number
TW095131384A
Other languages
Chinese (zh)
Other versions
TWI371281B (en
Inventor
Toshikazu Yoshikawa
Yuji Naito
Wataru Aoi
Toshiaki Takano
Akihiro Masuyama
Teppei Nakamura
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of TW200740444A publication Critical patent/TW200740444A/en
Application granted granted Critical
Publication of TWI371281B publication Critical patent/TWI371281B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A muscle pain suppressant, or functional food, that can be continuously taken on a daily basis, excelling in safety, and that can relieve or prevent the onset of muscle pain, being especially effective in the suppression of delayed onset muscle soreness. As an active ingredient, there is contained a fermented milk preferably exhibiting at least one of antioxidant enzyme developing potency, heat shock protein developing potency, and neutrotaxis and tissue infiltration inhibiting potency, which fermented milk is obtained by fermenting milk by the use of microbial cells containing Lactobacillus helveticus.
TW095131384A 2005-08-26 2006-08-25 Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitor TWI371281B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005246312 2005-08-26

Publications (2)

Publication Number Publication Date
TW200740444A true TW200740444A (en) 2007-11-01
TWI371281B TWI371281B (en) 2012-09-01

Family

ID=37771639

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095131384A TWI371281B (en) 2005-08-26 2006-08-25 Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitor

Country Status (3)

Country Link
JP (1) JP5198865B2 (en)
TW (1) TWI371281B (en)
WO (1) WO2007023896A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0770209A (en) * 1993-07-02 1995-03-14 Takeda Shokuhin Kogyo Kk Polysaccharide substance, nps, its production and use thereof
DE69430747T2 (en) * 1993-07-28 2003-03-06 Aventis Pharma Ltd CONNECTIONS AS PDE IV AND TNF INHIBITORS
CA2321737A1 (en) * 1998-03-04 1999-09-10 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
JP2003506324A (en) * 1999-07-09 2003-02-18 ファルマシア・コーポレイション Treatment of cyclooxygenase-2-mediated disorders using conjugated fatty acid compounds
CA2495952A1 (en) * 2002-08-21 2004-03-04 Kissei Pharmaceutical Co., Ltd. Preventive therapeutic composition for muscular fatigue, pulled muscle and disease attributed thereto
US20040204411A1 (en) * 2002-12-17 2004-10-14 Pharmacia Corporation Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
JP4680571B2 (en) * 2003-12-25 2011-05-11 カルピス株式会社 Moisturizer for ingestion

Also Published As

Publication number Publication date
TWI371281B (en) 2012-09-01
JPWO2007023896A1 (en) 2009-02-26
WO2007023896A1 (en) 2007-03-01
JP5198865B2 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
MY124559A (en) Anti-stress agent and functional food having anti-stress effect
MX348797B (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion.
ATE484574T1 (en) LACTOBACILLUS RHAMNOSUS WITH BODY FAT REDUCING ACTIVITY AND FOODS CONTAINING IT
WO2007027819A3 (en) Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
UA98629C2 (en) Compounds and methods for kinase modulation
WO2007087068A3 (en) Inhibitors of tyrosine kinases and uses thereof
EP2046943A4 (en) Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation
HK1073230A1 (en) Live bacterium preparation containing lactic acid bacterium as active ingredient and food containinglactic acid bacterium
NZ709704A (en) Protein formulations and methods of making same
ATE456369T1 (en) FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES
EP1852114A4 (en) COMPOSITION CONTAINING DIHOMO-(gamma)-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT
TW200700074A (en) Inducer of t cell apoptosis
WO2009040445A3 (en) Arabinoxylo-oligosaccharides useful against gastrointestinal infections
WO2005112976A3 (en) Probiotic compounds from lactobacillus gg and uses therefor
EP1938824A4 (en) Medicine, food and drink or feed containing sphingomyelin
WO2005081904A3 (en) Antimicrobial carbohydrates and methods of using same
EP1741437A4 (en) Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
WO2008149802A1 (en) Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient
ZA200703166B (en) Composition comprising lactic acid and lactoferrin
MX2012006629A (en) Probiotic microorganisms as active agents against changes in the skin's microrelief.
WO2005097146A3 (en) Dairy components effective for fat loss
IN2012DN02283A (en)
AU2003207417A1 (en) Use of tryptophan rich peptides
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
DE602008003199D1 (en) GLUCOSEISOMERASE FOR THE TREATMENT OF FRUCTOSE INCOMPATIBILITY

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees